Physician profile
James David Neel
NPI 1083879910
$7,482.28
in general payments reported to CMS, 2019-2025
38 companies · $427 in 2025
The $427 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,472 · 2020: $1,055 · 2021: $1,118 · 2022: $647 · 2023: $715 · 2024: $2,048 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,341 · Travel and Lodging: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,341.36 |
| Travel and Lodging | $848.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,977.97 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Penumbra, INC. | $1,447.45 | 2019-2025 | Indigo System, Penumbra System |
| Centinel Spine, LLC | $788.09 | 2024 | Prodisc L |
| Medtronic, INC. | $684.80 | 2022-2025 | Endurant Iis, Valiant Captivia, Penditure |
| Inari Medical, INC. | $447.52 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $415.85 | 2023-2024 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Abbott Laboratories | $235.78 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Atricure, INC. | $130.63 | 2019-2024 | |
| Medtronic Vascular, INC. | $125.66 | 2019-2020 | |
| Abiomed | $117.99 | 2022-2025 | |
| Bard Peripheral Vascular, INC. | $117.49 | 2024 | Venclose Maven Catheter |
| Cvrx, INC. | $115.69 | 2022 | |
| La Jolla Pharmaceutical Company | $106.25 | 2019-2020 | |
| Edwards Lifesciences Corporation | $92.54 | 2022-2025 | Edwards Intuity Elite Valve System, Konect Resilia |
| Chiesi USA, INC. | $72.88 | 2019-2023 | Cleviprex, Kengreal |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $68.36 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $39.23 | 2024 | Assure Wcd |
| Avanos Medical | $38.61 | 2019 | |
| Surmodics, INC. | $38.36 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Xl Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.20 | 2019 | |
| Corcym INC | $33.73 | 2023 | Perceval |
| E.R. Squibb & Sons, L.L.C. | $31.49 | 2022 | |
| Erbe USA INC | $31.43 | 2023 | Erbe Cryo2 |
| Pfizer INC. | $30.21 | 2022 | |
| Lemaitre Vascular, INC. | $25.99 | 2023 | Hydro Lemaitre Valvulotome |
| Reflow Medical INC | $22.55 | 2025 | |
| Shockwave Medical, INC | $22.11 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $22.01 | 2019 | |
| Ethicon US, LLC | $20.75 | 2019 | |
| Solventum Corporation | $20.24 | 2025 | Activ.A.C. |
| Medtronic USA, INC. | $18.89 | 2020 | |
| Centerline Biomedical INC. | $17.56 | 2022 | |
| Cagent Vascular INC | $16.34 | 2025 | Serrantor |
| Novo Nordisk INC | $15.17 | 2021 | |
| Boston Scientific Corporation | $14.88 | 2025 | Enroute Transcarotid Stent |
| Daiichi Sankyo INC. | $14.79 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.65 | 2022 | |
| Mallinckrodt Enterprises LLC | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Neel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.